2021

ASIA 2021

Axoltis Pharma announces to attend the annual meeting of the American Spinal Injury Association (ASIA) on 8-10th July 2021 in Saint-Louis (USA). Dr Sighild Lemarchant, Preclinical Project Manager, will present the poster #99 entitled « SCO-spondin-derived peptide promotes functional recovery in a mouse model of spinal cord injury ». A study done in collaboration with the lab of Dr Cédric G. Geoffroy, Assistant Professor of Texas A&M University.

BNA 2021

Axoltis Pharma announces to attend the annual meeting of British Neuroscience Association,  International BNA2021 Festival of Neuroscience  (12-15 April 2021 Online and Worldwide). Axoltis Pharma preclinical research team is proud to present a poster (#TP001135) demonstrating a subcommissural organ-spondin-derived peptide restoring memory in a mouse model of Alzheimer’s disease.

 

AD/PD 2021

Axoltis Pharma announces to attend the 15th International Conference on Alzheimer’s & Parkinson’s Diseases (AP/PD 2021) (digital on March9-14th 2020). Axoltis Pharma preclinical reseach team is proud to present 3 posters (#P193, #P594, #P625) demonstrating the efficacy of its innovative drug candidate, a SCO-spondin derived peptide, in Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and excitotoxicity.

 

2020

Neuroscience Virtual Partnering – 2020


Axoltis Pharma will attend Neuroscience Virtual Partnering on November 9-12. Yann Godfrin, Chief Executive Officer and Luca Bolliger, Chief Business Officer, will be delighted to meet you there and discuss potential partnerships for the development of our innovative drug-candidate for neurological disorders !

BIO Europe Digital 2020

Axoltis Pharma announces to attend BIO Europe 2020 Digital on October 26-29, with participation to the One-on-One Partnering event. This International Convention is one very important biotechnology event, drawing industry leaders. Yann Godfrin, Chief Executive Officer and Luca Bolliger, Chief Business Officer, will be delighted to meet you there and discuss potential partnerships for the development of our promising lead product !

WFNR & SOFMER 2020

Axoltis Pharma announces to attend the 11th World Congress for NeuroRehabilitation (WFNR annual meeting) jointly with the 35th Congress of the French Society of Physical and Rehabilitation Medecine annual (SOFMER annual meeting) (digital on October 7-11th 2020). Axoltis Pharma researcher team is proud to present 4 posters (#P0211, #P0212, #P0368, #P0651) demonstrating the efficacy of its innovative drug candidate, a SCO-spondin derived peptide, in cognitive impairement and traumatic spinal cord injury.

BIO 2020

Axoltis Pharma announces to attend BIO International Convention 2020 Digital on June 8-12, with participation to the Bio One-on-One Partnering event. The BIO International Convention is the world’s largest and most prestigious biotechnology event, drawing industry leaders from around the globe. Yann Godfrin, Chief Executive Officer and Luca Bolliger, Chief Business Officer, will be delighted to meet you there and discuss potential partnerships for the development of our promising products.

BIO Europe Spring 2019 – Digital

Axoltis Pharma announces to attend BIO Europe Spring Convention 2020 Digital on March 23-25, with participation to the One-on-One Partnering event. This International Convention is one very important biotechnology event, drawing industry leaders from around the globe. Yann Godfrin, Chief Executive Officer and Luca Bolliger, Chief Business Officer, will be delighted to meet you there and discuss potential partnerships for the development of our promising products.

2019

ISCoS 2019

Axoltis Pharma announces to attend the 58th International Spinal Cord Society (ISCoS) annual scientific meeting on November 5-7th at Nice, France. This is a great opportunity to meet with researchers from all over the world and arrange potential collaborative work.

NEUROSCIENCE 2019

Axoltis Pharma announces to attend NEUROSCIENCE 2019, the 50th Annual Meeting of the Society for Neuroscience, on October 19-23th at Chicago, Il, USA. NEUROSCIENCE is the world’s largest marketplace of ideas and tools for global neuroscience. This is a great opportunity to meet with researchers from all over the world and arrange potential collaborative work.

 

2019 PD Therapeutics Conference

Axoltis Pharma announces to attend MJFF 2019 Parkinson’s Disease Therapeutics Conference on October 15th at New York City, NY, USA. This meeting is The Michael J. Fox Foundation’s annual scientific conference and the only one in the world focused exclusively on Parkinson’s disease drug development. 

BioJapan 2019 & European Biotech Pharma Partnering Conference

Axoltis Pharma announces to attend BioJapan 2019. This Asia’s Premier Partnering Event for Biotechnology Industry will be held on October 9-11th at Pacifico Yokohama, Japan. On October 8th, Axoltis Pharma will also attend the European Biotech and Pharma Partnering Conference in Osaka, Japan. These are opportunities to meet us and discuss potential partnerships for the development of our promising products. Dr Yann GODFRIN, Chief Executive Officer, will be delighted to meet you there.

2019 International Congress of Parkinson’s Disease and Movement Disorders

Axoltis Pharma announces to attend the International Congress of Parkinson’s Disease and Movement Disorders Society (MDS), on September 22-26th at Nice, France. This is a great opportunity to meet with researchers and collaborators from all over the world and arrange potential collaborative work. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.

BIO 2019

Axoltis Pharma announces to attend BIO International Convention 2019 on June 3-6 in Philadelphia, PA – USA, with participation to the Bio One-on-One Partnering event. The BIO International Convention is the world’s largest and most prestigious biotechnology event, drawing industry leaders from around the globe. Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there and discuss potential partnerships for the development of our promising products.

NeuroFrance 2019

Axoltis Pharma announces to attend NeuroFrance 2019 on May 22-24th in Marseille, France. This international colloque is organised by the French Society of Neuroscience. Dr Yann GODFRIN, Chief Executive Officer, and Dr Manuel BLANC, Chief Scientific Officer, will be delighted to meet you there.